Myocardial Phosphoproteomics and Single Cardiomyocyte Force Measurements Endorse Dyrk1A as a Candidate Therapeutic Target for Incomplete Reverse Remodelling After Aortic Valve Replacement
AuthID
P-00Z-E3A
P-00Z-E3A